Haemonetics Corporation vs. ResMed Inc.
Haemonetics Corporation and ResMed Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| HAE | RMD | |
|---|---|---|
| Market Cap | $5.39 billion | $35.56 billion |
RMD leads on 1 of 1 size & scale factors.
Dividend
| HAE | RMD | |
|---|---|---|
| Dividend Yield | — | 1.04% |
HAE and RMD split the dividend factors evenly.
Risk & Sentiment
| HAE | RMD | |
|---|---|---|
| Short Interest | 1.81% | 4.14% |
HAE leads on 1 of 1 risk & sentiment factors.
Dig deeper: HAE overview, HAE financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.